Neurogene Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-36.32	-55.19	-60.69	-33.28	-69.44	-31.59	-50.18	-37	-21.86	-24.03	Upgrade
Depreciation & Amortization	3.96	3.81	2.28	1.82	0.53	0.29	0.36	0	0	0	Upgrade
Share-Based Compensation	1.42	1.25	11.56	5.62	7.68	4.7	3.84	1.97	1.51	0.85	Upgrade
Other Operating Activities	-20.48	-2.7	-0.7	1.26	45.84	-4.98	1.27	4.81	0.09	5.69	Upgrade
Operating Cash Flow	-51.42	-52.82	-47.56	-24.58	-15.39	-31.58	-44.72	-30.23	-20.27	-17.49	Upgrade
Capital Expenditures	-0.32	-2.23	-3.26	-2.22	-0.88	-0.05	-0.49	-0.71	-0.03	-0.09	Upgrade
Acquisitions	20.96	0	0	0	0.19	0	0	0	0	0	Upgrade
Change in Investments	5	0	0	0	0	56	64.51	-47.35	-47.51	-23.49	Upgrade
Investing Cash Flow	25.64	-2.23	-3.26	-2.22	-0.69	55.95	64.01	-48.06	-47.53	-23.57	Upgrade
Share Issuance / Repurchase	92.51	0.07	0.78	77.54	82.6	0.6	0.44	75.81	99.16	53.13	Upgrade
Debt Issued / Paid	-0.03	-0	-0.05	-0.05	-0.01	-0.03	-0.02	-0	0	-2.6	Upgrade
Other Financing Activities	-	66.46	-	-0.36	-0.35	-	-	-4.69	-6.21	-5.25	Upgrade
Financing Cash Flow	92.48	66.53	0.73	77.14	82.24	0.57	0.42	71.11	92.95	45.28	Upgrade
Exchange Rate Effect	0	0	0	0	0.01	-0.05	0.02	-0.05	-0.53	-0.32	Upgrade
Net Cash Flow	66.7	11.48	-50.09	50.34	66.17	24.9	19.73	-7.23	24.62	3.9	Upgrade
Free Cash Flow	-51.74	-55.05	-50.82	-26.79	-16.27	-31.63	-45.21	-30.94	-20.29	-17.57	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-126.50%	-	-	-	-	Upgrade
Free Cash Flow Per Share	-105.20	-139.54	-18.47	-10.34	-12.04	-26.89	-38.56	-32.75	-32.12	-40.55	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).